RESMED INC — Director's Dealing 2012

Nov 23, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-11-21

Reporting Person: Reiser Anne (President - ResMed Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-21	ResMed Common Stock	M	10286	$40.72	Acquired	30863.705	Direct
2012-11-21	ResMed Common Stock	M	5429	$40.72	Acquired	36292.705	Direct

Footnotes

F1: Represents acceleration of RSUs granted on 12/17/2009 to correct a clerical error and qualify for preferential tax treatment.

F2: Represents acceleration of RSUs granted on 11/11/2010 to correct a clerical error and qualify for preferential tax treatment.